Gilead Sciences in charts: Q2 base sales jump 10% on HIV, oncology growth despite Veklury drop
This is a summary aggregated from Seeking Alpha. Read the complete article on the original site:
Read full article at Seeking AlphaRelated stories
I type-check AI-generated SDK code against the real package. Claude refused a third of my Stripe tasks.
Dev.to · 9 min ago
Today's AI Cloud-Ops Agents Will Feel Primitive by Fall and Their Own Roadmaps Back It Up
Dev.to · 11 min ago
I spent two months cleaning with the Samsung Jet 95S stick vacuum and I’m shocked at how well it performs — and for a good price too
TechRadar · 14 min ago
WhatsApp just solved some of the most annoying group chat problems
Android Authority · 15 min ago
I Stopped Re-Explaining My Codebase to AI Agents. Here Is What I Built Instead.
Dev.to · 18 min ago
One LINE Official Account, Multiple Tools: Webhook and Token Architecture
Dev.to · 19 min ago